切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2017, Vol. 06 ›› Issue (05) : 384 -388. doi: 10.3877/cma.j.issn.2095-3232.2017.05.011

所属专题: 文献

临床研究

半肝血流阻断在腹腔镜肝细胞癌切除中的应用
何尹韬1, 陈应军1,(), 甄作均1   
  1. 1. 528000 广东省佛山市第一人民医院肝脏胰腺外科
  • 收稿日期:2017-06-21 出版日期:2017-10-10
  • 通信作者: 陈应军
  • 基金资助:
    佛山市科技局医学类科技攻关项目(2014AB00301)

Application of hemihepatic vascular occlusion in laparoscopic resection of hepatocellular carcinoma

Yintao He1, Yingjun Chen1,(), Zuojun Zhen1   

  1. 1. Department of Hepatic and Pancreatic Surgery, the First People's Hospital of Foshan, Foshan 528000, China
  • Received:2017-06-21 Published:2017-10-10
  • Corresponding author: Yingjun Chen
  • About author:
    Corresponding author: Chen Yingjun, Email:
引用本文:

何尹韬, 陈应军, 甄作均. 半肝血流阻断在腹腔镜肝细胞癌切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2017, 06(05): 384-388.

Yintao He, Yingjun Chen, Zuojun Zhen. Application of hemihepatic vascular occlusion in laparoscopic resection of hepatocellular carcinoma[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2017, 06(05): 384-388.

目的

探讨半肝血流阻断在腹腔镜肝细胞癌(肝癌)切除中的安全性及疗效。

方法

回顾性分析2013年1月至2015年12月佛山市第一人民医院收治的23例腹腔镜肝癌切除术患者临床资料。患者均签署知情同意书,符合医学伦理学规定。根据第一肝门血流阻断方式不同将患者分为半肝血流阻断组和Pringle组。其中半肝血流阻断组11例,男9例,女2例;年龄24~65岁,中位年龄46岁;采用腹腔镜下经肝门板半肝血流阻断。Pringle组12例,男10例,女2例;年龄31~66岁,中位年龄43岁;采用腹腔镜下Pringle法肝门血流阻断。观察两组患者术中、术后情况以及围手术期肝功能变化。两组肝功能、住院时间比较采用t检验。

结果

半肝血流阻断组术后7 d ALT、TB、ALB分别为(58±12) U/L、(29±2) μmol/L、(38±3) g/L,Pringle组相应为(80±24)U/L、(32±3) μmol/L、(34±4) g/L,差异有统计学意义(t=-2.739,-2.192,2.626;P<0.05)。半肝血流阻断组术后住院时间(5.9±0.9) d,明显短于Pringle组的(7.4±1.9)d(t=-2.382,P<0.05)。两组均无中转开腹,无发生围手术期死亡及肝衰竭、术后出血等严重并发症。

结论

腹腔镜肝癌切除术中采用半肝血流阻断安全、可行,与Pringle法相比,具有术后恢复快优势,是腹腔镜肝切除理想的肝血流阻断方法之一。

Objective

To investigate the safety and efficacy of hemihepatic vascular occlusion in laparoscopic resection of hepatocellular carcinoma (HCC).

Methods

Clinical data of 23 patients who underwent laparoscopic resection of HCC in the First People's Hospital of Foshan between January 2013 and December 2015 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. According to the vascular occlusion method of the porta hepatis, the patients were divided into the hemihepatic vascular occlusion group (n=11) and Pringle group (n=12). In the hemihepatic vascular occlusion group, 9 cases were males and 2 females, aged 24-65 years old with a median age of 46 years old, and laparoscopic hemihepatic vascular occlusion via the portal plate was performed. In the Pringle group, 10 cases were males and 2 females, aged 31-66 years old with a median age of 43 years old, and laparoscopic vascular occlusion of the porta hepatis with Pringle maneuver was performed. The intraoperative and postoperative conditions and liver function changes in the perioperative period were observed in two groups. Liver function and length of hospital stay were compared between two groups using t test.

Results

The ALT, TB and ALB levels at postoperative 7 d was respectively (58±12) U/L, (29±2) μmol/L, (38±3) g/L in the hemihepatic vascular occlusion group, and (80±24) U/L, (32±3) μmol/L, (34±4) g/L in the Pringle group, and significant differences were observed (t=-2.739, -2.192, 2.626; P<0.05). The postoperative length of hospital stay in the hemihepatic vascular occlusion group was (5.9±0.9) d, significantly shorter than (7.4±1.9) d in the Pringle group (t=-2.382, P<0.05). No patient was switched to open surgery, no death in the perioperative period was observed, and no liver failure, postoperative hemorrhage or other severe complications were observed in both groups.

Conclusions

Hemihepatic vascular occlusion is safe and feasible for laparoscopic resection of HCC. Compared with Pringle maneuver, it has the advantage of faster postoperative recovery. It is an ideal hepatic vascular occlusion method for laparoscopic hepatectomy.

表1 半肝血流阻断组和Pringle组腹腔镜肝癌切除术患者围手术期肝功能指标比较(±s
[1]
Minata M, Harada KH, Kudo M, et al. The prognostic value of vascular endothelial growth fator in hepatocellular carcinoma for predicting metastasis after curative resection[J]. Oncology, 2013, 84 Suppl 1:75-81.
[2]
Zhou S, Xue XJ, Li RR, et al. A comparative study assessing a new tool for occluding parenchymal blood flow during liver resection for hepatocellular carcinoma[J]. S Afr J Surg, 2013, 51(1):12-15.
[3]
Herman P, Perini MV, Coelho FF, et al. Laparoscopic resection of hepatocellular carcinoma: when, why, and how? a single-center experience[J]. J Laparoendosc Adv Surg Tech A, 2014, 24(4):223-228.
[4]
Zhen ZJ, Lau WY, Wang FJ, et al. Laparoscopic liver resecion for hepatocellular carcinoma in the left liver: pringle maneuver versus tourniquet method[J]. World J Surg, 2010, 34(2):314-319.
[5]
夏锋,王曙光,别平,等.Pringle法导致的肝脏缺血再灌注损伤对肝癌肝切除患者预后的影响[J].中华消化外科杂志,2009,8(2):103-106.
[6]
尹天圣,易亚阳,毛熙贤,等.肝癌肝切除术后肝衰竭危险因素的Meta分析[J].临床肝胆病杂志,2014,30(10):1009-1014.
[7]
丁义涛,江春平.肝切除术后肝功能衰竭:病理生理、危险因素与临床治疗[J].中华肝胆外科杂志,2011,17(4):279-282.
[8]
Chen YJ, Zhen ZJ, Chen HW, et al. Laparoscopic liver resection under hemihepatic vascular inflow occlusion using the lowering of hilar plate approach[J]. Hepatobiliary Pancreat Dis Int, 2014, 13(5):508-512.
[9]
Fu SY, Lau WY, Li GG, et al. A prospective randomized controlled trial to compare Pringle maneuver, hemihepatic vascular inflow occlusion, and main portal vein inflow occlusion in partial hepatectomy[J]. Am J Surg, 2011, 201(1):62-69.
[10]
陈焕伟,邓斐文,王峰杰,等.腹腔镜肝外格立森鞘外右肝蒂血流阻断新技术应用[J/CD].中华腔镜外科杂志(电子版),2014,7(1):18-22.
[11]
李未祥,侯辉,耿小平.腹腔镜肝切除血管阻断方式的应用[J].腹腔镜外科杂志,2016,21(9):648-652.
[12]
Lau WY, Lai EC, Lau SH. Methods of vascular control technique during liver resection: a comprehensive review[J]. Hepatobiliary Pancreat Dis Int, 2010, 9(5):473-481.
[13]
陈焕伟,王峰杰,李梅生,等.腹腔镜解剖性肝切除术:附40例报告[J].中华肝胆外科杂志,2012,18(10):773-776.
[14]
范国勇,甄作均,陈焕伟,等.腹腔镜经肝门板半肝血流阻断在左半肝切除中的应用[J/CD].消化肿瘤杂志(电子版),2011,3(2):78-81.
[15]
陈焕伟,王峰杰,邓斐文,等.腹腔镜解剖性肝切除治疗肝细胞癌:附30例报告[J/CD].中华腔镜外科杂志(电子版),2015,8(2):41-44.
[16]
刘允怡.肝切除与肝移植应用解剖学[M].北京:人民卫生出版社,2010:27-34.
[17]
陈应军,甄作均,吴志鹏,等.腹腔镜下降肝门板半肝血流阻断在解剖性肝切除术中的应用[J].中华消化外科杂志,2015,14(4): 339-343.
[18]
李梅生,李清汉,甄作均.肝门Glisson鞘内选择性血流阻断在腹腔镜左半肝切除术中的临床应用[J/CD].消化肿瘤杂志(电子版),2015,7(4):197-199.
[19]
梁力建,王卫东,黄雄庆,等.低中心静脉压减少肝切除术中出血的临床研究[J].中华外科杂志,2005,43(23):1522-1523.
[20]
魏珂,程波,何开华,等.控制性低中心静脉压用于不同类型肝切除术患者的血液保护效应[J].中华麻醉学杂志,2013,33(12):1451-1453.
[21]
刘昌军,杨尽晖,易为民,等.右半肝血流阻断在肝右后叶解剖性切除术中的应用[J/CD].中华肝脏外科手术学电子杂志,2016,5(2):77-80.
[22]
Wang PF, Li CH, Chen YW, et al. Preserving hepatic artery flow during portal triad blood inflow occlusion improves remnant liver regeneration in rats after partial hepatectomy[J]. J Surg Res, 2013, 181(2):329-336.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[3] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[4] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[5] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[6] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[9] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[10] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[11] 李博, 贾蓬勃, 李栋, 李小庆. ERCP与LCBDE治疗胆总管结石继发急性重症胆管炎的效果[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 60-63.
[12] 韩戟, 杨力, 陈玉. 腹部形态CT参数与完全腹腔镜全胃切除术术中失血量的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 88-91.
[13] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[14] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[15] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?